ES2486844T3 - Sustancia que presenta propiedad antidepresiva - Google Patents

Sustancia que presenta propiedad antidepresiva Download PDF

Info

Publication number
ES2486844T3
ES2486844T3 ES04722121.3T ES04722121T ES2486844T3 ES 2486844 T3 ES2486844 T3 ES 2486844T3 ES 04722121 T ES04722121 T ES 04722121T ES 2486844 T3 ES2486844 T3 ES 2486844T3
Authority
ES
Spain
Prior art keywords
substance presenting
antidepressant
property
antidepressant property
presenting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES04722121.3T
Other languages
English (en)
Inventor
Valentina Ivanovna Akhapkina
Roman Vitalievich Akhapkin
Yury Anatolievich Aleksandrovsky
Alla Sergeevna Avedisova
Tatyana Aleksandrovna Voronina
Vladimir Viktorovich Nesteruk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2486844T3 publication Critical patent/ES2486844T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

N-carbamoil-metil-4-fenil-2-pirrolidona para ser usada en el tratamiento de la depresión.

Description

imagen1
imagen2
imagen3
imagen4
imagen5

Claims (1)

  1. imagen1
ES04722121.3T 2003-04-10 2004-03-19 Sustancia que presenta propiedad antidepresiva Expired - Lifetime ES2486844T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2003110288/15A RU2232578C1 (ru) 2003-04-10 2003-04-10 Вещество, обладающее антидепрессивной активностью
RU2003110288 2003-04-10
PCT/RU2004/000106 WO2004089893A1 (en) 2003-04-10 2004-03-19 Substance exhibiting antidepressant property

Publications (1)

Publication Number Publication Date
ES2486844T3 true ES2486844T3 (es) 2014-08-19

Family

ID=33157471

Family Applications (1)

Application Number Title Priority Date Filing Date
ES04722121.3T Expired - Lifetime ES2486844T3 (es) 2003-04-10 2004-03-19 Sustancia que presenta propiedad antidepresiva

Country Status (12)

Country Link
US (1) US20060287383A1 (es)
EP (1) EP1619182B1 (es)
CA (1) CA2521923C (es)
CY (1) CY1115549T1 (es)
DK (1) DK1619182T3 (es)
EA (1) EA009044B1 (es)
ES (1) ES2486844T3 (es)
PL (1) PL1619182T3 (es)
PT (1) PT1619182E (es)
RU (1) RU2232578C1 (es)
SI (1) SI1619182T1 (es)
WO (1) WO2004089893A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LV13630B (en) * 2006-03-16 2007-12-20 Olainfarm As Method of preparation and use of pharmaceutically active n-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone
RU2329804C2 (ru) 2006-03-28 2008-07-27 Валентина Ивановна Ахапкина Вещество, обладающее нейротропной - нейромодуляторной активностью
RU2423969C2 (ru) * 2007-10-12 2011-07-20 Старрайд Фармасьютикал Лимитед Способ микронизации n-карбамоил-метил-4-фенил-2-пирролидона и лекарственный препарат, содержащий вододиспергируемую органическую лекарственную субстанцию в виде микронизированного порошка n-карбамоил-метил-4-фенил-2-пирролидона
RU2391976C2 (ru) * 2007-10-18 2010-06-20 Открытое Акционерное Общество "Валента Фармацевтика" Фармацевтический состав в виде микроинкапсулированных поликомпонентных частиц из n-карбамоил-метил-4-фенил-2-пирролидона и вспомогательного нейтрального органического низкомолекулярного компонента и способ его микрокапсулирования
RU2392915C1 (ru) * 2009-04-14 2010-06-27 Федеральное государственное учреждение "Новокузнецкий научно-практический центр медико-социальной экспертизы и реабилитации инвалидов Федерального агентства по здравоохранению и социальному развитию" (ФГУ ННПЦ МСЭ и РИ Росздрава) Способ формирования двигательных функций у инвалидов с позвоночно-спинно-мозговой травмой
RU2437659C1 (ru) * 2010-11-12 2011-12-27 Государственное образовательное учреждение высшего профессионального образования "Российский государственный педагогический университет им. А.И. Герцена" (РГПУ им. А.И. Герцена) Средство, обладающее антидепрессивным, анксиолитическим и ноотропным действием
RU2480214C1 (ru) * 2011-09-22 2013-04-27 Валентина Ивановна Ахапкина Состав, обладающий модуляторной активностью с соразмерным влиянием, фармацевтическая субстанция (варианты), применение фармацевтической субстанции, фармацевтическая и парафармацевтическая композиция (варианты), способ получения фармацевтических составов
EA024165B1 (ru) * 2013-10-31 2016-08-31 Ооо "Тева" Лекарственная форма n-карбамоилметил-4-фенил-2-пирролидона, способ ее получения и применение

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956314A (en) * 1970-07-24 1976-05-11 U.C.B., Societe Anonyme Derivatives of 2-pyrrolidinone
DE2423390A1 (de) * 1974-05-14 1975-12-04 Hoechst Ag Pyroglutamylverbindungen mit antidepressiver wirkung und verfahren zu ihrer herstellung
BE864269A (fr) * 1977-03-03 1978-06-16 Parke Davis & Co Nouveaux n-(aminoalkyl substitue)-2-oxo-1-pyrrolidine-acetamides et procedes pour les produire
SU797219A1 (ru) * 1979-05-08 1995-07-25 Ленинградский государственный педагогический институт им.А.И.Герцена N-карбамоилметил-4-фенил-2-пирролидон, обладающий гипотензивной активностью
RU2050851C1 (ru) * 1990-08-28 1995-12-27 Институт медико-биологических проблем Вещество, проявляющее ноотропную активность
ES2204932T3 (es) * 1994-09-12 2004-05-01 Eli Lilly And Company Limited Moduladores serotonergicos.
EA002380B1 (ru) * 1999-07-21 2002-04-25 Российский Государственный Педагогический Университет Им. А.И.Герцена Антиишемическое средство
DE19936521A1 (de) * 1999-08-06 2001-02-15 Gruenenthal Gmbh Substituierte Pyrrolidin-2,3,4-trion-3-oxim-Derivate
GB0004297D0 (en) * 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses

Also Published As

Publication number Publication date
SI1619182T1 (sl) 2014-12-31
EP1619182A4 (en) 2010-01-06
EP1619182A1 (en) 2006-01-25
EA009044B1 (ru) 2007-10-26
CA2521923A1 (en) 2004-10-21
CA2521923C (en) 2009-05-19
US20060287383A1 (en) 2006-12-21
EA200501491A1 (ru) 2006-04-28
WO2004089893A1 (en) 2004-10-21
DK1619182T3 (da) 2014-08-11
RU2232578C1 (ru) 2004-07-20
PT1619182E (pt) 2014-09-24
EP1619182B1 (en) 2014-07-23
CY1115549T1 (el) 2017-01-04
PL1619182T3 (pl) 2015-01-30

Similar Documents

Publication Publication Date Title
ES2665917T3 (es) Endoxifeno para su uso en el tratamiento del cáncer
ES2602986T3 (es) Nuevas composiciones cosméticas y/o farmacológicas y sus aplicaciones
ES2502472T3 (es) Composición adhesiva para su uso en un inmunosensor
ES2489741T3 (es) Composición para la prevención de la aparición de acontecimientos cardiovasculares
ES2496092T3 (es) El uso de amisulprida para tratar náuseas y vómitos posoperatorios
ES2483725T3 (es) Composición básica cosmética y su uso
ES2629749T3 (es) Inmunidad tumoral
ES2552651T3 (es) Composición inyectable de polidesoxirribonucleótido para el tratamiento de enfermedades osteoarticulares
ES2532481T3 (es) Agente anti-obesidad y alimento anti-obesidad
BRPI0413363A (pt) formas de dosagem fornecendo liberação controlada de inibidores de proteìna de transferência de ésteres de colesterila e liberação imediata de inibidores de hmg-coa redutase
ECSP077401A (es) Medicamentos que contienen compuestos de carbonilo y su uso
AR048878A1 (es) Composiciones topicas de metadona y metodos para usarlas
ECSP045491A (es) Nueva sal formiato de o-desmetil venlafaxina
CL2008003284A1 (es) Compuestos derivados de 4-bencilamino-1-carboxiacil-piridina, inhibidores cetp; composicion farmaceutica que los comprende; combinacion farmaceutica; y uso en el tratamiento de enfermedades metabolicas, ateroesclerosis y cardiovasculares, entre otras.
AR031283A1 (es) Composicion y metodo de dieta para animales
ES2564172T3 (es) Utilización de una composición cosmética para el cuidado de las pieles grasas
ES2531516T3 (es) Uso de escina
ES2487496T3 (es) Agente para aliviar el síndrome metabólico
ES2526912T3 (es) Composición farmacéutica que contiene neurotoxina botulínica A2
ES2629309T3 (es) Formulaciones de tratamiento de la mucositis inducida por terapia antitumoral o inmunosupresora
MX2007000117A (es) Una composicion de combinacion.
ES2581331T3 (es) Inhibidor de la progresión de una enfermedad atribuida a una acumulación anormal de grasa hepática
ES2526913T3 (es) Composición farmacéutica que contiene neurotoxina 2 botulínica
ES2550351T3 (es) Liposoma termolábil con una temperatura de liberación regulada
ES2550461T3 (es) Uso de S-adenosilmetionina (SAM) y superóxido dismutasa (SOD) para la preparación de medicamentos para el tratamiento de la enfermedad de Alzheimer